Capricor Therapeutics Inc (CAPR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

8840 WILSHIRE BLVD BEVERLY HILLS, CA 90211

Capricor Therapeutics, Inc., is a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class cell and exosome-based therapeutics for the treatment and prevention of diseases. Capricor's lead candidate, CAP-1002, is an allogeneic cell therapy that is currently in clinical development for the treatment of Duchenne muscular dystrophy and the cytokine storm associated with COVID-19. Capricor is also investigating the field of extracellular vesicles and exploring the potential of exosome-based candidates to treat or prevent a variety of disorders. We are now developing two potential vaccines for COVID-19 as part of our exosome platform.

Data as of 2021-10-09 09:33:06 -0400
Market Cap85.873 Million Shares Outstanding23.022 Million Avg 30-day Volume1.683 Million
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.11 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.45286 52-week High/Low8.4 / 3.13 Next Earnings Date2021-11-11 Price to Cash FLow (P/CF) -22.7837
Data provided by IEX Cloud
View SEC Filings from CAPR instead.

View recent insider trading info

Funds Holding CAPR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CAPR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SABAR KARIMAH ES

  • Director
115,000 2021-07-23 2

DUNBAR GEORGE W JR

  • Director
0 2021-01-04 1

COLLIER EARL M JR

  • Director
0 2021-01-04 1

MUSKET DAVID B

  • Director
0 2021-01-04 1

LITVACK FRANK

  • Director
0 2021-01-04 1

MARBAN LINDA CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-01-04 1

KRASNEY KAREN EVP, GENERAL COUNSEL

  • Officer
0 2021-01-04 1

BERGMANN ANTHONY CHIEF FINANCIAL OFFICER

  • Officer
0 2021-01-04 1

MANZO LOUIS

  • Director
0 2021-01-04 1

ASCHEIM DEBORAH CHIEF MEDICAL OFFICER

  • Officer
0 2018-07-24 0

KAZAM JOSHUA A

  • Director
0 2018-01-02 0

SMITH RACHEL VICE PRESIDENT OF R&D

  • Officer
0 2018-01-02 0

CEDARS SINAI MEDICAL CENTER

  • 10% Owner
4,049,959 2017-05-09 0

MARBAN EDUARDO

  • 10% Owner
3,307,863 2016-12-31 0

GRASMICK LOUIS J

  • Director
1,136,755 2016-03-16 0

GERSHELL LELAND CHIEF FINANCIAL OFFICER

  • Officer
2,100 2016-03-16 0

ST. JOHN EDWARD A.

EDWARD ST. JOHN, LLC

  • 10% Owner
5,175,958 2016-03-16 0

SCHAFER GREGORY W

  • Director
0 2015-03-03 0

HAMER ANDREW WARWICK VP OF MEDICAL AFFAIRS

  • Officer
0 2015-03-03 0

DAVIES ANTHONY CHIEF TECHNOLOGY OFFICER

  • Officer
0 2013-11-20 0

ST. JOHN EDWARD A.

MD BTI, LLC

EDWARD ST. JOHN, LLC

  • 10% Owner
5,047,221 2013-11-20 0

HORTON DARLENE P PRESIDENT & CEO

  • Officer
  • Director
0 2012-08-06 0

BREWER RICHARD B EXECUTIVE CHAIRMAN

  • Officer
  • Director
125,000 2012-03-30 0

EVANS DARON CHIEF FINANCIAL OFFICER

  • Officer
36,252 2012-03-30 0

LIEU HSIAO EXECUTIVE VP, CLINICAL DEV.

  • Officer
12,600 2012-03-30 0

KASH PETER M

  • Director
2,258,327 2011-07-18 0

GRANADILLO PEDRO P

  • Director
27,588 2011-05-10 0

BELLDEGRUN ARIE

  • Director
711,420 2011-05-10 0

MIEYAL PAUL A

  • Director
0 2011-05-10 0

TANEN DAVID M

  • Director
No longer subject to file 2009-12-31 0

STRUMPH PETER M CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2009-01-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 22:15:04 UTC -7.6737 7.7437 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 21:45:03 UTC -7.6737 7.7437 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 21:15:03 UTC -7.6737 7.7437 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 20:45:03 UTC -7.6737 7.7437 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 20:15:03 UTC -7.6737 7.7437 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 19:45:03 UTC -7.6737 7.7437 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 19:15:04 UTC -7.6737 7.7437 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 18:45:03 UTC -7.7494 7.8194 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 18:15:03 UTC -7.7494 7.8194 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 17:45:03 UTC -7.7494 7.8194 950000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 17:15:03 UTC -7.7494 7.8194 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 16:45:03 UTC -7.501 7.571 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 16:15:03 UTC -7.501 7.571 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 15:45:03 UTC -7.501 7.571 1000000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 15:15:03 UTC -7.501 7.571 900000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 14:45:02 UTC -7.7929 7.8629 900000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 14:15:03 UTC -7.7929 7.8629 900000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 13:45:03 UTC -7.7929 7.8629 900000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 13:15:03 UTC -7.7929 7.8629 900000
CAPRICOR THERAPEUTICS INC CAPR 2021-10-15 12:45:03 UTC -7.7929 7.8629 900000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CAPR -400.0 shares, $-2052.0 2021-06-30 N-PORT

Elevate your investments